A Study of RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent.

NCT00353522 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

135

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Heart Disease

Interventions

DRUG: Placebo
DRUG: dalcetrapib

Sponsor

Hoffmann-La Roche